We Told You So — These IBD 50 Stocks Dominate This Year

Core Insights - The Innovator IBD 50 ETF (FFTY) has outperformed the S&P 500 significantly, returning 19.2% this year compared to the S&P 500's 0.7% return [1] - The strong performance of the IBD 50 index is attributed to its heavy weighting in gold stocks, which are not included in the S&P 500 [1] Performance Comparison - The IBD 50 ETF is the top performer among actively traded U.S. diversified ETFs, followed by Schwab US Dividend Equity (SCHD) with a return of 16.2% [1] - Coeur Mining (CDE) is the top position in the IBD 50 index, with a weight of 3.75% and a share price increase of over 35% this year [1] - IamGold (IAG) is the second-largest position, with a weight of 3.6% and a share price increase of 36% over the past year [1] Key Holdings - The third largest position in the ETF is Stoke Therapeutics (STOK), which has seen a price increase of over 6% this year [1] - Micron Technology (MU) is also a significant holding, with a weight of 3.3% in the IBD 50 ETF and a share price increase of 33% this year [1] - Other notable positions include AngloGold Ashanti (AU), Kinross Gold (KGC), and Applied Optoelectronics (AAOI), all contributing to the ETF's strong performance [1]